MENU
TENX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Tenax Therapeutics (TENX) Ownership - Who owns Tenax Therapeutics?

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension... Show more

Profile

Industry
Medical Specialties
Address
101 Glen Lennox Drive
Phone
+1 919 855-2100
Employees
6
Web
https://www.tenaxthera.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
284.61M
P/E Ratio
2.41
Total Cash
99.37M
Projected Growth
N/A
Total Debt
278.8K
Revenue
N/A
Risk (Beta)
-0.06
Dividend Yield
N/A
Total Cash/Share
3.75
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
TENX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of novel therapeutic products

Industry Biotechnology

Profile
Details
Industry
Medical Specialties
Address
101 Glen Lennox Drive
Phone
+1 919 855-2100
Employees
6
Web
https://www.tenaxthera.com